Percutaneous device closure for secundum atrial septal defects (ASDs) has been performed commonly and safely with high success rates. However, it is still challenging to close ASDs that are surrounded with deficient or hypermobile rims and could be compromised with an unexpected migration of device. We report a case of percutaneous Amplazter Septal Occluder (ASO; St. Jude Medical Inc., St. Paul...

Swiss-cheese atrial septal defect (ASD) is a malformation characterized by multi-fenestrated interatrial defects. Here, we describe vignette of 23-year-old man with Swiss-Cheese ASD two defects areas 0.74 cm2 and 0.44 cm2, complicated an aneurysm successfully repaired cribriform amplatzer occluder (ASO) via the percutaneous transcatheter approach. This case emphasizes importance attaining clear...

Ventricular septal defect concurrent with left ventricular aneurysm is unusual in postinfarction patients. The complex anatomy is challenging for occluder deployment in transcatheter closure and associated with high risk of aneurysm perforation. We present a case of transcatheter closure of a large postinfarction ventricular septal defect with an Amplatzer septal occluder in a 71-year-old woman...

The use of the Tandem Heart percutaneous ventricular assist device (Tandem Heart pVAD, Cardiac Assist technologies, Pittsburgh, PA) as a bridge to recovery or to other cardiopulmonary support systems has been rising. One requirement for placement of this device is an intraatrial septostomy which is usually closed during the surgical insertion of more permanent ventricular assist devices. We pre...

Transcatheter device closure of secundum atrial septal defect is a well known option since 1974. The procedure is routinely performed through femoral vein approach but rarely inferior venacava (IVC) may be interrupted or blocked so transfemoral approach cannot be an option in these patients. In such rare cases surgical closure can be performed but in cases of percutaneous closure of secundum at...

AIM We sought to investigate the safety and efficacy of Cardio-O-Fix septal occluder (CSO) in percutaneous closure of atrial septal defects (ASD) as compared to the Amplatzer septal occluder (ASO). METHODS A consecutive of 351 patients received transcatheter ASD closure with CSO or ASO from July 2004 to October 2010 were studied. The ASDs were divided into simple- (isolated defects <26 mm) or...

OBJECTIVES Amplatzer septal occluder (ASO)-associated cardiac perforation (CP) at our institution prompted this retrospective review. BACKGROUND Cardiac perforation is a rare complication after transcatheter atrial septal defect (ASD) closure. METHODS To identify CP after transcatheter ASD closure with ASO, cardiac events (CE) describing definite CP, hemopericardium, pericardial effusion, c...

Tricuspid valve (TV) injury following transcatheter closure of perimembranous ventricular septal defect (PMVSD) with Amplatzer ductal occluder I (ADO I), requiring surgical repair, is rare. We report two cases of TV tear involving the anterior and septal leaflets following PMVSD closure using ADO I. In both the patients, the subvalvular apparatus remained unaffected. The patients presented with...